Technical Analysis for TTPH - Tetraphase Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 1.29 -7.19% -0.10
TTPH closed down 7.19 percent on Friday, January 18, 2019, on 1.52 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TTPH trend table...

Date Alert Name Type % Chg
Jan 18 Fell Below 20 DMA Bearish 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 17 NR7 Range Contraction -7.19%
Jan 17 NR7-2 Range Contraction -7.19%
Jan 17 Wide Bands Range Expansion -7.19%
Jan 16 NR7 Range Contraction -8.51%
Jan 16 Wide Bands Range Expansion -8.51%
Jan 15 New Downtrend Bearish -9.15%
Jan 15 20 DMA Support Bullish -9.15%

Older signals for TTPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections through its chemistry technology. Its principal products include eravacycline, an intravenous and oral antibiotic that use as a empiric monotherapy has completed the Phase II clinical trials for the treatment of multi-drug resistant Gram-negative infections; and eravacycline oral formulation that is in Phase I clinical trials to treat complicated urinary tract infections in intravenous-to-oral step-down therapy. The company's products that are under development comprise TP-834; and TP-271 that is in preclinical trials for the treatment of respiratory diseases caused by bacterial biothreat pathogens, as well as engages in the development of Pseudomonas/Gram-negative program. Tetraphase Pharmaceuticals, Inc. was founded in 2006 and is based in Watertown, Massachusetts.
Is TTPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.59
52 Week Low 1.01
Average Volume 685,291
200-Day Moving Average 2.7962
50-Day Moving Average 1.6054
20-Day Moving Average 1.3035
10-Day Moving Average 1.441
Average True Range 0.135
ADX 23.85
+DI 16.6728
-DI 22.816
Chandelier Exit (Long, 3 ATRs ) 1.265
Chandelier Exit (Short, 3 ATRs ) 1.415
Upper Bollinger Band 1.6493
Lower Bollinger Band 0.9577
Percent B (%b) 0.48
BandWidth 53.057154
MACD Line -0.0492
MACD Signal Line -0.0732
MACD Histogram 0.024
Fundamentals Value
Market Cap 65.86 Million
Num Shares 51.1 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -0.46
Price-to-Sales 58.89
Price-to-Book 2.16
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.47
Resistance 3 (R3) 1.49 1.44 1.44
Resistance 2 (R2) 1.44 1.40 1.44 1.43
Resistance 1 (R1) 1.37 1.37 1.35 1.35 1.42
Pivot Point 1.32 1.32 1.31 1.32 1.32
Support 1 (S1) 1.25 1.28 1.23 1.23 1.16
Support 2 (S2) 1.20 1.25 1.20 1.15
Support 3 (S3) 1.13 1.20 1.14
Support 4 (S4) 1.11